Picture of Icure Pharmaceutical logo

175250 Icure Pharmaceutical Share Price

0.000.00%
kr flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+19.33%
3m+16.63%
6m+2.74%
1yr-33.66%
Volume Change (%)
10d/3m+398.48%
Price vs... (%)
52w High-37.75%
50d MA+8.48%
200d MA-0.14%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-32.3%
Return on Equity-42.55%
Operating Margin-37.38%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueKR₩m60,922.4990,144.2164,282.8559,367.1156,806.34n/an/a11.26%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Icure Pharmaceutical EPS forecast chart

Profile Summary

Icure Pharmaceutical Incorporation is a Korea-based company mainly engaged in the production and sale of cosmetics. Along with subsidiaries, the Company operates its business through two segments. The Cosmetic segment is involved in the manufacturing and sale of cosmetics including basic cosmetics, mask packs, and patches. In addition, it is also engaged in the production and sale of body, hair care products and fragrances. The cosmetics are sold under the names of Botalinum, Mediheal N.M.F, Meditime, among others. The Pharmaceutical segment is engaged in the manufacturing and sale of over the counter (OTC) drugs, ethical the counter (ETC) drugs, as well as quasi drugs. The OTC drugs include anti-inflammatory analgesics and dementia treatments. The Company distributes its products within the domestic market and to overseas markets.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    March 31st, 2024
    Incorporated
    May 29th, 2000
    Public Since
    July 12th, 2018
    No. of Shareholders
    29,034
    Sector
    Personal & Household Products & Services
    Industry
    Consumer Defensives
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    37,369,685
    Blurred out image of a map
    Address
    Icure Tower, SEOUL, 06170
    Web
    https://www.icure.co.kr
    Phone
    +82 269596909
    Auditors
    Sahmduk Accounting Corp.

    175250 Share Price Performance

    Upcoming Events for 175250

    Q2 2024 Icure Pharmaceutical Inc Earnings Release

    Q3 2024 Icure Pharmaceutical Inc Earnings Release

    Similar to 175250

    Picture of Barunson Co logo

    Barunson Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Bbia Co logo

    Bbia Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of BeautySkin Co logo

    BeautySkin Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Bonne Co logo

    Bonne Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of C&C International Co logo

    C&C International Co

    kr flag iconKorea Exchange - KOSDAQ

    FAQ